Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
about
Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report.Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysisDistinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.Estimation of α/β for late rectal toxicity based on RTOG 94-06Radiation dose-volume effects in radiation-induced rectal injury.Hypofractionated external-beam radiotherapy for prostate cancer.Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers.New insights for pelvic radiation disease treatment: Multipotent stromal cell is a promise mainstay treatment for the restoration of abdominopelvic severe chronic damages induced by radiotherapy.Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications.Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials.Stereotactic body radiation therapy for prostate cancer.Current role of spacers for prostate cancer radiotherapy.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerSpacer application for prostate cancer radiation therapy.Toxicity and efficacy of three dose-fractionation regimens of intensity-modulated radiation therapy for localized prostate cancer.Hypofractionation for prostate cancer.Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer.Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Early closure of phase II prospective study on acute and late tolerance of hypofractionated radiotherapy in low-risk prostate cancer patients.Modeling of alpha/beta for late rectal toxicity from a randomized phase II study: conventional versus hypofractionated scheme for localized prostate cancer.Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.Rectal planning risk volume correlation with acute and late toxicity in 3-dimensional conformal radiation therapy for prostate cancer.Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion.Factors Predicting Late Rectal Disorders after Radiation Therapy for Prostate Cancer.Optimal number and sizes of the doses in fractionated radiotherapy according to the LQ model.Fractionated abdominal irradiation induces intestinal microvascular changes in an in vivo model of radiotherapy-induced gut toxicity.Acute and late complications after hypofractionated intensity modulated radiotherapy in prostate cancer.Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis.Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.The contribution of the cone beam Kv CT (CBKvCT) to the reduction in toxicity of prostate cancer treatment with external 3D radiotherapy
P2860
Q33461784-6DFC4DCA-2B9B-4ED5-88A9-3B704628CA28Q34500966-0950706E-902E-415E-9420-6C6B7E9B81DAQ35040098-F883502D-C623-4144-A9F2-6C1181997A67Q35186584-1570C770-4A04-41FD-9033-B2664E9F2FF8Q35870610-8C600BD9-3577-4064-A938-666318F19B3FQ36711751-89382DCD-C8F5-4C38-907B-C7B8BF9D76F6Q37138297-47FEF84F-AEEB-4093-9551-37875759BC5CQ37266540-93CCD537-8F8E-44E5-9357-94C40B42740BQ37380104-3A05B904-B65B-4B33-9F07-25C490090C55Q37539431-596AEE57-82A8-412F-8B9F-C607B9E7848BQ37932543-D6605316-49EF-48AD-B511-102B69835E91Q38931064-6CD5792D-B38D-4B31-9A6E-9ADD6CB983C7Q38981805-BE9A0847-2DEE-4AD0-8BDA-C17B6D3D071EQ39198013-2C567F99-76F9-4DE6-8DE8-772AA7926EB2Q39375431-2C4CF0E8-FFD3-4844-871D-7E1BD0A22CA3Q40004846-01A20DF3-6DB5-4E16-988B-8CB82A51457EQ40055572-9A4B3A2B-A61B-40AC-8E45-0C29AC92B1F0Q41276603-F59DB15B-51D0-4DA5-9D9C-57BFC8BBC1EDQ41877449-3AEBA734-4CB3-489B-8628-640F2BC03BFBQ42537131-6FF6F34E-B509-4E97-88DC-FB4820BBBB59Q42571229-D256E14D-F241-4BAC-823A-8D2BF56F2E0EQ44057423-3A19CD22-D332-458D-A9A8-CE0AB3604654Q45341495-09B53115-749F-4B75-9C8E-DACF17CEE3C2Q47141907-5E8905E5-59BD-4A52-94C1-714A0DC24DA1Q47560995-98DF90D6-AFA9-4B0E-9BF9-E9B873AD7FA3Q47866555-D9625EC8-8DCB-4930-B673-942241F0F16FQ48141226-2090FE59-7D9B-4DB6-9BF2-09055B201258Q48394956-D5D94165-17B6-4CE2-9BA3-11D34E2888A4Q48623725-D80C422D-88A6-4201-AFE1-24CE80102B2CQ48958679-B56F528B-365B-44DA-946D-B9B735E7E45AQ58656934-9F6BE5B4-DDA6-40AB-BD9B-857D48F3CCF1
P2860
Rectal bleeding after hypofractionated radiotherapy for prostate cancer: correlation between clinical and dosimetric parameters and the incidence of grade 2 or worse rectal bleeding.
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@ast
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@en
type
label
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@ast
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@en
prefLabel
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@ast
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@en
P2093
P1476
Rectal bleeding after hypofrac ...... de 2 or worse rectal bleeding.
@en
P2093
Hideo Niibe
Hidetoshi Yamanaka
Hiroyuki Muramatsu
Jun-Ichi Saito
Kazuto Ito
Koichi Harashima
Kouhei Kurokawa
Masami Yamada
Mitsuhiro Takahashi
Norio Mitsuhashi
P304
P356
10.1016/J.IJROBP.2004.07.695
P407
P577
2004-11-01T00:00:00Z